Moventa Topical Gel 0.2% + 2%

Moventa Topical Gel is a dual-action topical formulation combining Mucopolysaccharide Polysulphate + Salicylic Acid (0.2%+2%) from Ziska Pharmaceuticals Ltd. Priced at ৳200.00 per 30g tube, this Topical Gel offers targeted relief for musculoskeletal discomfort while ensuring cost-effective treatment.

Clinically indicated for inflammatory pain management, Moventa treats muscular aches, sprains, rheumatic pain, and mild arthritis. Its unique formula combines anti-inflammatory heparinoid activity with keratolytic action, enabling deeper penetration for localized relief without systemic exposure. The gel format allows easy application with massage-enhanced absorption.

Adults and children over 12 apply 5-15 cm gel strips 4x daily. Contraindicated in pregnancy trimesters and breastfeeding mothers. Store below 30°C, protected from moisture. Rare side effects include transient redness (<1% cases), warranting discontinuation if persistent.

This NSAID-alternative demonstrates triple-action pharmacology:

• PGE2/LTB4 inflammatory pathway modulation
• Hyaluronidase inhibition reducing edema
• Keratolytic skin conditioning

Avoid concurrent use with anticoagulants or potassium-elevating drugs.

Adults & children above 12 years: Apply 5-15 cm gel to affected area up to 4 times daily. Do not use for children under 12. Maximum recommended duration: 2 weeks without medical supervision.

Like all medicines, this gel preparation can cause side effects, although not everybody gets them. Rarely, this medicine can cause the following in sensitive individuals: redness, burning sensation and rash. If any of these occur, stop using the gel and consult with a doctor.

Contraindicated in first/third trimesters. Avoid breast area during lactation. Consult doctor if planning pregnancy.

External use only. Avoid eye contact. May cause irritation in sensitive skin/hot climates. Wash hands after application. Inform doctor about bleeding disorders or renal issues.

Geriatric patients can use standard dosage. Hepatic/renal impairment requires caution. Pediatric safety data insufficient.